Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Reexamination Certificate
2005-10-25
2005-10-25
Richter, Johann (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
C514S230500
Reexamination Certificate
active
06958396
ABSTRACT:
The invention relates to the novel mesylate of a phenylpiperazine derivative of the formula (I). This salt has favorable properties as compared with the free base of this compound.
REFERENCES:
patent: 5002948 (1991-03-01), Perregaard et al.
patent: 5242925 (1993-09-01), Boettcher et al.
patent: 5532241 (1996-07-01), Bottcher et al.
patent: 5576321 (1996-11-01), Krushinski, Jr. et al.
patent: 5693655 (1997-12-01), Bottcher et al.
patent: 6214829 (2001-04-01), Feenstra et al.
patent: 6251908 (2001-06-01), Bottcher et al.
patent: 6262087 (2001-07-01), Perregaard et al.
patent: 6314896 (2001-11-01), Marin et al.
patent: 6352988 (2002-03-01), Perregaard et al.
patent: 6391896 (2002-05-01), Van Hes et al.
patent: 6552044 (2003-04-01), Perregaard et al.
patent: 6828325 (2004-12-01), Feenstra et al.
patent: 2001/0020095 (2001-09-01), Perregaard et al.
patent: 2001/0021777 (2001-09-01), Perregaard et al.
patent: 41 27 849 (1993-02-01), None
patent: 43 33 254 (1995-04-01), None
patent: 44 14 113 (1995-10-01), None
patent: 197 30 989 (1999-01-01), None
patent: 0 376 607 (1990-07-01), None
patent: 0 722 941 (1996-07-01), None
patent: 1075156 (1967-07-01), None
patent: HU 218 935 (1995-10-01), None
patent: WO 97/17343 (1997-05-01), None
patent: WO 98/28293 (1998-07-01), None
patent: WO 99/03855 (1999-01-01), None
patent: WO 99/05140 (1999-02-01), None
patent: WO 99/67237 (1999-12-01), None
patent: WO 01/14330 (2001-03-01), None
patent: WO 03/068207 (2003-08-01), None
Robichaud et al., “Recent Advances in Dopamine D3and D4Receptor Modulation,”Ann. Rep. Med. Chem.35:11-21 (2000).
Tenbrink et al., “Recent Advances in Dopamine D3and D4Receptor Ligands and Pharmacology,”Ann. Rep. Med. Chem.29:43-51 (1994).
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Nwaonicha Chukwuma
Richter Johann
Solvay Pharmaceuticals B.V.
LandOfFree
8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-m... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-m..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-m... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3468416